Clinical Trial Update: A Multicenter Study to Evaluate the ROX Arteriovenous Coupler in Patients With Treatment-Resistant Hypertension [Phase 3]

View source ↗

Summary

A Phase 3 multicenter trial evaluating the ROX Arteriovenous Coupler for treatment-resistant hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• ROX Arteriovenous Coupler (ROX Arteriovenous Coupler)

Snippet

Sponsor: ROX Medical, Inc. | Conditions: Hypertension | Phase 3 | Status: COMPLETED